|
End-of-day quote
NSE India S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 1,874.50 INR | +0.03% |
|
-6.05% | +37.38% |
| 08-06 | Emcure Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 06, 2026 | |
| 08-06 | Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| Market Cap | 355B 3.71B 3.2B 3.01B 2.74B 5.15B 5.23B 35.36B 13.86B 178B 13.93B 13.62B 592B | P/E 2026 |
32.7x | P/E 2027 * | 29.7x |
|---|---|---|---|---|---|
| Enterprise Value | 362B 3.78B 3.26B 3.07B 2.79B 5.25B 5.33B 36.03B 14.12B 181B 14.19B 13.88B 603B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.42x |
| Free-Float |
18.23% | Yield 2026 |
0.23% | Yield 2027 * | 0.21% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | +0.03% | ||
| 1 week | -6.05% | ||
| Current month | -4.37% | ||
| 1 month | +5.12% | ||
| 3 months | +9.95% | ||
| 6 months | +27.46% | ||
| Current year | +37.38% |
| 1 week | 1,861.1 |  | 2,023 |
| 1 month | 1,776.5 | | 2,048 |
| Current year | 1,381 | | 2,048 |
| 1 year | 1,260 | | 2,048 |
| 3 years | 889 | | 2,048 |
| 5 years | 889 | | 2,048 |
| 10 years | 889 | | 2,048 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 1981-04-15 | |
| Director of Finance/CFO | - | 2003-09-30 | |
| Compliance Officer | - | 2026-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 73 | 2001-07-22 | |
| Director/Board Member | 75 | 1981-04-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -6.05% | +28.85% | - | 3.72B | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,055B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 632B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 442B | |
| +1.35% | -3.27% | +40.98% | +39.91% | 351B | |
| +1.75% | -0.98% | +26.20% | +39.73% | 290B | |
| +2.13% | -1.53% | +1.85% | +9.40% | 243B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 227B | |
| +1.35% | -3.20% | -9.07% | -53.51% | 200B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 172B | |
| Average | +2.16% | -1.97% | +31.05% | +48.99% | 361.62B | |
| Weighted average by Cap. | +2.78% | -1.88% | +44.16% | +68.06% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 956M 825M 777M 706M 1.33B 1.35B 9.11B 3.57B 45.79B 3.59B 3.51B 153B | 106B 1.11B 955M 898M 816M 1.54B 1.56B 10.54B 4.13B 52.97B 4.15B 4.06B 176B |
| Net income | 9.81B 102M 88.44M 83.21M 75.62M 142M 144M 976M 383M 4.91B 384M 376M 16.34B | 11.94B 125M 108M 101M 92.06M 173M 176M 1.19B 466M 5.97B 468M 458M 19.9B |
| Net Debt | 6.75B 70.44M 60.84M 57.24M 52.03M 97.85M 99.29M 671M 263M 3.38B 264M 259M 11.24B | 6.38B 66.63M 57.55M 54.15M 49.21M 92.56M 93.92M 635M 249M 3.19B 250M 245M 10.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | ₹1,874.50 | +0.03% | 136,782 |
| 26-08-17 | ₹1,873.90 | -3.02% | 220,968 |
| 26-08-14 | ₹1,932.30 | -3.85% | 132,011 |
| 26-08-13 | ₹2,009.60 | 0.00% | 54,656 |
| 26-08-12 | ₹2,009.60 | +0.55% | 214,106 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
